Full Text View
Tabular View
No Study Results Posted
Related Studies
Comparative Study of the Effect of Dysport and Botox
This study has been completed.
First Received: February 12, 2007   No Changes Posted
Sponsor: Laserklinik Karlsruhe
Information provided by: Laserklinik Karlsruhe
ClinicalTrials.gov Identifier: NCT00434863
  Purpose

The purpose of this study is to test the effect of Dysport and Botox on forehead wrinkles and EMG activity.


Condition Intervention Phase
Aging
 Drug: botulinum toxin type A
 Phase IV

Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Active Control, Single Group Assignment, Safety/Efficacy Study
Official Title: A Comparative Randomized Double-Blinded Study of the Effect of Dysport and Botox on Forehead Wrinkles and EMG Activity

Resource links provided by NLM:

MedlinePlus related topics: Botox
Drug Information available for: Clostridium botulinum toxin
U.S. FDA Resources

Further study details as provided by Laserklinik Karlsruhe:

Primary Outcome Measures:
  • EMG Muscular Activity at baseline and 0.5, 1, 2, 4, 8 and 10 weeks after injection, followed by weekly examinations for a total observation period of 20 weeks
  • Frown Wrinkle Severity (photographs and questionnaire) at baseline and 0.5, 1, 2, 4, 8 and 10 weeks after injection, followed by weekly examinations for a total observation period of 20 weeks

Secondary Outcome Measures:
  • Side Effects upon completion of the study (20 weeks after injection)

Estimated Enrollment: 24
Study Start Date: October 2005
Estimated Study Completion Date: March 2006
  Eligibility

Ages Eligible for Study:   30 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • age between 30 and 70 years
  • moderate to severe hyperfunctional forehead wrinkles at maximum contraction and at rest

Exclusion Criteria:

  • application of botulinum toxin products for a period of 12 months prior to the study
  • any significant health disturbances
  • facial nerve palsy, and any facial conditions that could confound safety or efficacy results
  • pregnancy and breast-feeding
  • neuromuscular diseases
  • drugs interfering with neuromuscular function (e.g. aminoglycosides)
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00434863

Locations
Germany, BW
Laserklinik Karlsruhe
Karlsruhe, BW, Germany, 76133
Sponsors and Collaborators
Laserklinik Karlsruhe
Investigators
Principal Investigator: Syrus Karsai, MD Laserklinik Karlsruhe
  More Information

No publications provided

Study ID Numbers: CR-015-LK/2005
Study First Received: February 12, 2007
Last Updated: February 12, 2007
ClinicalTrials.gov Identifier: NCT00434863     History of Changes
Health Authority: Germany: Ethics Commission

Keywords provided by Laserklinik Karlsruhe:
botulinum toxin type A
Dysport®
Botox®
hyperfunctional forehead lines
 randomized controlled trial
double-blinded trial
electromyogram (EMG)

Additional relevant MeSH terms:
Botulinum Toxins
Anti-Dyskinesia Agents
Therapeutic Uses
Physiological Effects of Drugs
Neuromuscular Agents
 Peripheral Nervous System Agents
Botulinum Toxin Type A
Central Nervous System Agents
Pharmacologic Actions

ClinicalTrials.gov processed this record on February 08, 2010



Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services